Skip to main content
Loading

First Wave BioPharma, Inc.

October 17, 2023
Franciscan B
Gastrointestinal
Company Description: First Wave BioPharma, Inc. is a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. First Wave is currently advancing a therapeutic development pipeline populated with multiple clinical stage programs built around its two proprietary technologies – the biologic adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients, and niclosamide, an oral small molecule with anti-viral and anti-inflammatory properties.
Speakers
James Sapirstein, Chairman and CEO - Entero Therapeutics (formerly First Wave BioPharma)